Europe Bromelain Market Forecast to 2030 - Regional Analysis - by Source and Application

The Europe bromelain market was valued at US$ 11.72 million in 2022 and is expected to reach US$ 20.79 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.

Increasing Applications in Pharmaceutical & Nutraceutical Industry Fuels the Europe Bromelain Market

Bromelain is used in the pharmaceutical industry as an anti-tumorigenic, anti-inflammatory, and anti-thrombotic agent. Moreover, it can prevent diseases such as bronchitis, sinusitis, and thrombophlebitis. It has been studied for its platelet aggregation inhibition, anti-edematous, anti-thrombotic, and fibrinolytic activities. It is also known for its ability to aid in digestion and wound-healing enhancement. Owing to these therapeutic actions, it is extensively used in pharmaceutical formulas and health supplements. The growing focus on maintaining optimum digestive and gut health boosts the demand for bromelain in dietary supplement manufacturing.

Bromelain is also applied in treating inflammation and swelling of the nose and sinuses after an injury or surgery. The anti-inflammatory and analgesic properties of bromelain make it an effective treatment for pain, soft tissue swelling, and joint stiffness associated with osteoarthritis. Bromelain improves functionality and decreases pain in mild acute knee pain and osteoarthritis. According to the World Health Organization (WHO), nearly 528 million people worldwide were living with osteoarthritis in 2019, recording an increase of 113% since 1990. Therefore, the rising applications of bromelain in the pharmaceutical & nutraceutical industries fuels the market growth.

Europe Bromelain Market Overview

The Europe bromelain market is segmented into Germany, France, Italy, the UK, Russia, and the Rest of Europe. The market growth in Europe is ascribed to the increasing acceptance of bromelain in cosmetics, dietary supplements, and other applications. Transforming lifestyle trends concerning the food & beverages industry further boosts the Europe bromelain market growth in the region. In the bakery industry, bromelain is used as a dough improver and flavor enhancer. According to the UK Federation of Bakers Ltd, the bakery industry is one of the largest segments in the food & beverages sector. Bromelain manufacturers are developing novel products to cater to the increasing demand from the food & beverages industry. For instance, in August 2021, ENZYBEL GROUP, a Belgium-based company, launched a new bromelain product called bromelain K, developed specifically for food & beverages applications such as meat tenderization, protein hydrolyzer, and flavor enhancer.

Bromelain is extensively used as a health supplement in Germany and other Western European countries and is also applied in treating inflammation and swelling of the nose and sinus after an injury or surgery. In addition, bromelain improves functionality and decreases pain in mild acute knee pain and knee osteoarthritis. According to a report by Versus Arthritis, published in early 2023, 10 million people in Europe have osteoarthritis, and 5.4 million people are estimated to have knee osteoarthritis. Such high incidences of orthopedic diseases boost the demand for bromelain-based supplements.

Europe has a well-established personal care industry, and it is one of the most prominent markets for cosmetics and other personal care products. Bromelain-based beauty supplements enhance skin strength and elasticity, thus providing an anti-wrinkle effect to the skin. Bromelain-based skincare products enhance the appearance of dry and damaged skin and are used to treat acne. The improving financial conditions across the region result in increased per capita expenditure on cosmetic and personal care products. According to Cosmetics Europe, an association of personal care product manufacturers, skincare had the most considerable market value among all the categories related to the cosmetics industry in the European Union in 2020. The growing demand for cosmetic products indicates the increasing need for bromelain in Europe.

Europe Bromelain Market Revenue and Forecast to 2030 (US$ Thousand)

Europe Bromelain Market Segmentation

The Europe bromelain market is segmented into source, application, and country.

Based on source, the Europe bromelain market is bifurcated stem and fruit. The stem market segment held a larger share in 2022.

In terms of application, the Europe bromelain market is categorized into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The food & beverages segment held the largest share in 2022.

Based on country, the Europe bromelain market is segmented Germany, France, Italy, the UK, Russia, and the Rest of Europe. The Rest of the Europe dominated the Europe bromelain market in 2022.

Challenge Bioproducts Co Ltd, Creative Enzymes, Enzybel International SA, and Medikonda Nutrients are some of the leading companies operating in the Europe bromelain market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bromelain market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Europe bromelain market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution